Maze Therapeutics exchanges stock for warrants
- Exchanged 2,776,007 shares for warrants
- Warrants allow purchase of 2,776,007 shares
- Outstanding shares now 53,931,889
MAZE
Maze Therapeutics, Inc. SEC filings
Every EDGAR filing for Maze Therapeutics, Inc. (MAZE), newest first, with AI summaries and stories.
- Ticker
- MAZE
- CIK
- 1842295
- Sector
- Biotech and pharma
- Latest filing
- 2d
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Also: 4 open-market sales ($1.6M), 2 grants or exercises.
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KMaze Therapeutics, Inc.MAZELIVE ROUTINE4Maze Therapeutics, Inc.MAZELIVE 2 insider filings
Jason V Coloma, insider filing for MAZE
Show all 2
- 4Insider filing for MAZE
- 4Insider filing for MAZE
Jason Coloma V
ROUTINE4Maze Therapeutics, Inc.MAZELIVE Atul Dandekar, insider filing for MAZE
Atul Dandekar
ROUTINE144Maze Therapeutics, Inc.MAZELIVE 2 Form 144 notices
Harold Bernstein, planned sale of MAZE shares
Show all 2
- 144Planned insider sale of MAZE shares
- 144Planned insider sale of MAZE shares
Harold Bernstein
ROUTINE4Maze Therapeutics, Inc.MAZELIVE Harold Bernstein, insider filing for MAZE
Harold Bernstein, reporting
ROUTINE144Maze Therapeutics, Inc.MAZELIVE Harold Bernstein, planned sale of MAZE shares
Harold Bernstein, reporting
ROUTINE4Maze Therapeutics, Inc.MAZELIVE 4 insider filings
Phillips Courtney, insider filing for MAZE
Show all 4
- 4Insider filing for MAZE
- 4Insider filing for MAZE
- 4Insider filing for MAZE
- 4Insider filing for MAZE
Phillips Courtney, reporting
ROUTINE4Maze Therapeutics, Inc.MAZELIVE 4 insider filings
Atul Dandekar, insider filing for MAZE
Show all 4
- 4Insider filing for MAZE
- 4Insider filing for MAZE
- 4Insider filing for MAZE
- 4Insider filing for MAZE
Atul Dandekar, reporting
ROUTINE144Maze Therapeutics, Inc.MAZELIVE 4 Form 144 notices
Phillips Courtney, planned sale of MAZE shares
Show all 4
- 144Planned insider sale of MAZE shares
- 144Planned insider sale of MAZE shares
- 144Planned insider sale of MAZE shares
- 144Planned insider sale of MAZE shares
Phillips Courtney, reporting
ROUTINE144Maze Therapeutics, Inc.MAZELIVE Jason V Coloma, planned sale of MAZE shares
Jason Coloma V, reporting
ROUTINE4Maze Therapeutics, Inc.MAZELIVE Atul Dandekar, insider filing for MAZE
Atul Dandekar, reporting
ROUTINE4Maze Therapeutics, Inc.MAZELIVE 4 insider filings
Sophie Kornowski, insider filing for MAZE
Show all 4
- 4Insider filing for MAZE
- 4Insider filing for MAZE
- 3New insider at MAZE
- 3New insider at MAZE
Sophie Kornowski, reporting
ROUTINE8-KMaze Therapeutics, Inc.MAZELIVE ROUTINE4Maze Therapeutics, Inc.MAZELIVE Harold Bernstein, insider filing for MAZE
Harold Bernstein, reporting
ROUTINESCHEDULE 13G/AMaze Therapeutics, Inc.MAZELIVE Ownership stake disclosure by Paradigm Biocapital Advisors LP (amended)
Paradigm Biocapital Advisors LP, filed by
NOTABLE10-QMaze Therapeutics, Inc.MAZELIVE ROUTINE8-KMaze Therapeutics, Inc.MAZELIVE ROUTINE4Maze Therapeutics, Inc.MAZELIVE Jason V Coloma, insider filing for MAZE
Jason Coloma V, reporting
ROUTINE144Maze Therapeutics, Inc.MAZELIVE Jason V Coloma, planned sale of MAZE shares
Jason Coloma V, reporting
ROUTINE4Maze Therapeutics, Inc.MAZELIVE Atul Dandekar, insider filing for MAZE
Atul Dandekar, reporting
ROUTINE144Maze Therapeutics, Inc.MAZELIVE Atul Dandekar, planned sale of MAZE shares
Atul Dandekar, reporting
ROUTINESCHEDULE 13GMaze Therapeutics, Inc.MAZELIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
ROUTINE4Maze Therapeutics, Inc.MAZELIVE 2 insider filings
Harold Bernstein, insider filing for MAZE
Show all 2
- 4Insider filing for MAZE
- 4Insider filing for MAZE
Harold Bernstein, reporting
ROUTINE144Maze Therapeutics, Inc.MAZELIVE 2 Form 144 notices
Harold Bernstein, planned sale of MAZE shares
Show all 2
- 144Planned insider sale of MAZE shares
- 144Planned insider sale of MAZE shares
Harold Bernstein, reporting
ROUTINE4Maze Therapeutics, Inc.MAZELIVE Atul Dandekar, insider filing for MAZE
Atul Dandekar, reporting
ROUTINE4Maze Therapeutics, Inc.MAZELIVE Jason V Coloma, insider filing for MAZE
Jason Coloma V, reporting
ROUTINE4Maze Therapeutics, Inc.MAZELIVE 6 insider filings
Daniel K Spiegelman, insider filing for MAZE
Show all 6
- 4Insider filing for MAZE
- 4Insider filing for MAZE
- 4Insider filing for MAZE
- 4Insider filing for MAZE
- 4Insider filing for MAZE
- 4Insider filing for MAZE
Daniel K Spiegelman, reporting
ROUTINE8-KMaze Therapeutics, Inc.MAZELIVE ROUTINE4Maze Therapeutics, Inc.MAZELIVE Jason V Coloma, insider filing for MAZE
Jason Coloma V, reporting